| Literature DB >> 34031647 |
Parsa P Salehi1, Sina J Torabi1, Yan Ho Lee1, Babak Azizzadeh2,3.
Abstract
OBJECTIVES: The objectives of this study include characterizing the practice patterns and testing strategies of facial plastic and reconstructive surgery (FPRS) fellowship directors (FDs) secondary to COVID-19 and to quantify the impact of COVID-19 on FPRS fellowship training. STUDYEntities:
Keywords: COVID-19; FPRS; SARS-CoV-2; coronavirus; facial plastics; fellow; fellowship; pandemic; public health; quality improvement; residency; telemedicine; training; virus
Year: 2021 PMID: 34031647 PMCID: PMC8127772 DOI: 10.1177/2473974X211014130
Source DB: PubMed Journal: OTO Open ISSN: 2473-974X
Fellowship Director Preoperative Testing Protocols (N = 45).
| No. (%) | |
|---|---|
| At this time, in your practice area, how would you characterize the incidence of COVID-19 cases? | |
| Rising | 2 (4.4) |
| Stable | 28 (62.2) |
| Falling | 14 (31.1) |
| I am not sure | 1 (2.2) |
| How are you routinely screening/testing your patients for COVID-19 in the preoperative setting?[ | |
| Screening questionnaire | 34 (75.6) |
| Temperature check | 35 (77.8) |
| Upper airway swab (viral test) | 44 (97.8) |
| Serology/blood draw (antibody test) | 3 (6.7) |
| I am not routinely testing patients[ | 1 (2.2) |
| No. of preoperative testing modalities utilized[ | |
| 1 | 8 (18.2) |
| 2 | 2 (4.5) |
| 3 | 32 (72.7) |
| 4 | 2 (4.5) |
| For those who selected upper airway swab[ | |
| One negative test within 24-48 h of surgery | 8 (18.2) |
| One negative test within 24-72 h of surgery | 19 (43.2) |
| One negative test within 1-5 d of surgery | 16 (35.6) |
| Two negative tests within 1-7 d of surgery[ | 1 (2.3) |
| Why are you screening/testing your patients for COVID-19 in the preoperative setting?[ | |
| Personal preference for patient safety | 25 (56.8) |
| Personal preference for health care worker safety | 28 (63.6) |
| Mandated by health system I practice/operate under[ | 32 (72.7) |
| Mandated by local/state government | 8 (17.8) |
| In your best estimate, what percentage of your patients scheduled for surgery have tested positive for COVID-19 in the preoperative period via any methods you use?[ | |
| None (0.0) | 13 (29.5) |
| >0 to ≤1 | 18 (40.9) |
| >1 to ≤3 | 11 (24.4) |
| >3 to ≤5 | 2 (4.4) |
| >5[ | 0 (0.0) |
| Are you routinely testing your patients for COVID-19 in the immediate postoperative setting? | |
| No | 22 (48.9) |
| Yes | 23 (51.1) |
| Screening questionnaire | 18 (78.3) |
| Temperature check | 21 (91.3) |
| Upper airway swab[ | 2 (8.7) |
| Serology/blood draw (antibody test)[ | 1 (4.3) |
Participants were allowed to choose >1 response.
Exclusive response.
Of 44 applicable responses.
Not a preset answer choice: an individual types in this regimen with “and a negative antibody test.”
One respondent wrote the following under “other”: “allows IV sedation anesthesia by center rules instead of general.” This fellowship director was recategorized to “mandated by health system I practice/operate under.”
Presented as >5% to ≤10%, >10% to ≤15%, >15% to ≤20%, >20%.
Answer choice erroneously stated “preoperative” instead of “postoperative.”
Fellowship Director Attitudes Toward Preoperative Testing.
| No. (%) | |
|---|---|
| Universal preoperative COVID-19 testing . . . | |
| Is cost-effective | 30 (66.7) |
| Does not substantially affect health care costs | 12 (26.7) |
| Creates unnecessary health care costs | 3 (6.7) |
| Universal preoperative COVID-19 testing . . . | |
| Improves patient safety | 36 (80.0) |
| Does not substantially affect patient safety | 9 (20.0) |
| Universal preoperative COVID-19 testing . . . | |
| Improves health care worker safety | 43 (95.6) |
| Does not improve health care worker safety | 2 (4.4) |
| Universal preoperative COVID-19 testing . . . | |
| Is burdensome for patients | 21 (46.7) |
| Is not burdensome for patients | 24 (53.3) |
Figure 1.COVID-19–induced change in (A) patient willingness to have surgery, (B) surgeon volume, and (C) fellow training.